ARCHIVES

Isis 3521 Gets Fast-track Status For FDA Review.

This article is from The Cancer Letter archive.

Vol. 26 No. 44 | December 1, 2000

Download PDF Visit The Full Archive

Related Articles

Intergroup 5-FU/Levamisole Study Positive Enough Now To End Untreated Control Arms

September 22, 1989

R.S.K. Young Quits As FDA Oncology Group Leader

July 11, 1980

MD Anderson Researcher Charged With Placing Ethylene Glycol In Colleague’s Coffee

June 14, 2013

NCI Okays Agreement Between Allegheny, Pitt, Over NSABP

February 3, 1995

Metastasis Research Is Example Of Progress Under 1971 Cancer Act

May 10, 1991

Healthcare Utilization Figures More Than Biology In Disparity

April 30, 2010